香港航天科技(01725.HK)續漲30% 料7月首發試驗農業衛星星座
香港航天科技(01725.HK)預計7月首發試驗農業衛星星座,該股由11個月低位三連升,承昨天急升29%突破20天及10天線勢,今天逆市進一步突破50天及百天線(18.6元及22.24元),報23.65元即市高位,續漲30%,成交續增至近80萬股,涉資1,683萬元。
香港航天科技公佈,「金紫荊—齊魯衛星星座」第一期將由9顆衛星組成,其建造和發射將於今年完成。其中首發試驗星「金紫荊衛星六號」預計今年7月發射。該衛星星座將服務於粵港澳大灣區和齊魯大地的農業估產、農業資源調查、災害預報及智慧城市建設等方面業務。(sz/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.